Atlas Trials

Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer

Clinical trial NCT03080428 · WITHDRAWN

Trial details

NCT number
NCT03080428
Sponsor
UNICANCER
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
ER-positive Her2-negative Early Breast Cancer
Start date
2017-05-01
Primary completion
2018-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.